hypogonadotropic hypogonadism

Approach to the male patient with congenital hypogonadotropic hypogonadism.

Kallmann syndrome and hypogonadotropic hypogonadism do not exist as distinct conditions.

Andropause is preceded by a condition called Hypogonadotropic hypogonadism.

Induction of spermatogenesis in men with primary and secondary hypogonadotropic hypogonadism).

These characteristics are known as hypogonadotropic hypogonadism.

Obesity increases the risk of hypogonadotropic hypogonadism.

In hypogonadotropic hypogonadism, blood gonadotropin levels are uninterpretable.

The term congenital hypogonadotropic hypogonadism (CHH) is now often used.

Kisspeptin was found to play a role in hypogonadotropic hypogonadism in 2003, which was supported by several independent lab groups.

The fertile eunuch syndrome is a cause of hypogonadotropic hypogonadism caused by a lutheinizing hormone deficiency.

When these hormones are not present in the correct amounts, the signs and symptoms of adrenal insufficiency and hypogonadotropic hypogonadism can result.

Kallmann syndrome is a part of a group of conditions that come under the term hypogonadotropic hypogonadism (HH).

In 1944, he described a congenital endocrine condition (hypogonadotropic hypogonadism with anosmia) that has come to be known as Kallmann's syndrome.

Individuals with Kallmann syndrome experience anosmia (lack of smell) and do not go through puberty (hypothalamic hypogonadotropic hypogonadism).

Mutations in this gene result in both X-linked congenital adrenal hypoplasia and hypogonadotropic hypogonadism.

Hypogonadotropic hypogonadism (a lack of the pituitary hormones luteinizing hormone and follicle-stimulating hormone)

Loss of DAX1 function leads to adrenal insufficiency and hypogonadotropic hypogonadism, which are the main characteristics of this disorder.

This condition results from the enlarging tumor interfering with the normal function of gonadotropin pituitary cells resulting in secondary hypogonadotropic hypogonadism and infertility.

Defects in the GNRHR are a cause of hypogonadotropic hypogonadism (HH).

These disruptions to the GnRH system cause reproductive disorders like hypogonadotropic hypogonadism or Kallmann Syndrome.

Secondary - defect lies outside of the gonad: e.g. Polycystic ovary syndrome, and Kallmann syndrome, also called hypogonadotropic hypogonadism.

According to the researchers, these relatively low levels of LH and FSH are suggestive of a "partial" hypogonadotropic hypogonadism.

Kallmann syndrome (KS) and other forms of hypogonadotropic hypogonadism (HH) are classed as pituitary or endocrine disorders.

GnRH analogues like nafarelin and busurelin are used for the treatment of anovulatory infertility, hypogonadotropic hypogonadism, delayed puberty and cryptorchidism.